Simple Summary Prostate cancer is one of the most common male cancers. A more accurate
disease assessment is needed to better stratify patients' risks and guide treatment decisions …

Simple Summary Most men with prostate cancer will live as long as those who do not have
prostate cancer. However, some men will die early of their disease due to a particular type of …

Background Prostate cancer (PC) is the most frequently diagnosed cancer in North
American men. Pathologists are in critical need of accurate biomarkers to characterize PC …

Purpose: This systematic review and meta-analysis aimed to assess the prognostic impact of
intraductal carcinoma of the prostate in patients with prostate cancer. Materials and …

Aim Lymph node metastases (pN1) at prostatectomy are infrequent but impact prognosis.
Traditional prostate nomograms assess age, serum prostatic-specific antigen (PSA), clinical …

Prostate cancer is a common malignancy, but only some tumors are lethal. Accurately
identifying these tumors will improve clinical practice and instruct research. Aggressive …

Intraductal carcinoma of the prostate, a unique histopathologic entity that is often observed
(especially in advanced prostate cancer), is characterized by the proliferation of malignant …

Context The optimal management for men with prostate cancer (PCa) with unconventional
histology (UH) is unknown. The outcome for these cancers might be worse than for …

Intraductal carcinoma of the prostate (IDC-P), a clinicopathological entity characterized by
malignant prostatic epithelial cells growing within ducts and/or acini, has a distinct …

Simple Summary Prostate cancer is a common and challenging disease among men,
prompting researchers to explore new ways to understand and manage it effectively. In this …